187 related articles for article (PubMed ID: 36225208)
1. Daily requirement of softgel thyroxine is independent from gastric juice pH.
Virili C; Capriello S; Stramazzo I; Brusca N; Santaguida MG; Gargano L; Bagaglini MF; Bruno G; Severi C; Centanni M
Front Endocrinol (Lausanne); 2022; 13():1002583. PubMed ID: 36225208
[TBL] [Abstract][Full Text] [Related]
2. Thyroxine Treatment With Softgel Capsule Formulation: Usefulness in Hypothyroid Patients Without Malabsorption.
Trimboli P; Virili C; Centanni M; Giovanella L
Front Endocrinol (Lausanne); 2018; 9():118. PubMed ID: 29619010
[TBL] [Abstract][Full Text] [Related]
3. Thyroxine softgel capsule in patients with gastric-related T4 malabsorption.
Santaguida MG; Virili C; Del Duca SC; Cellini M; Gatto I; Brusca N; De Vito C; Gargano L; Centanni M
Endocrine; 2015 May; 49(1):51-7. PubMed ID: 25595886
[TBL] [Abstract][Full Text] [Related]
4. Tablet and oral liquid L-thyroxine formulation in the treatment of naïve hypothyroid patients with Helicobacter pylori infection.
Ribichini D; Fiorini G; Repaci A; Castelli V; Gatta L; Vaira D; Pasquali R
Endocrine; 2017 Sep; 57(3):394-401. PubMed ID: 27848196
[TBL] [Abstract][Full Text] [Related]
5. Levothyroxine treatment and gastric juice pH in humans: the proof of concept.
Virili C; Bruno G; Santaguida MG; Gargano L; Stramazzo I; De Vito C; Cicenia A; Scalese G; Porowska B; Severi C; Centanni M
Endocrine; 2022 Jun; 77(1):102-111. PubMed ID: 35477833
[TBL] [Abstract][Full Text] [Related]
6. Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors.
Vita R; Saraceno G; Trimarchi F; Benvenga S
J Clin Endocrinol Metab; 2014 Dec; 99(12):4481-6. PubMed ID: 25259910
[TBL] [Abstract][Full Text] [Related]
7. Comparison of TSH Levels with Liquid Formulation Versus Tablet Formulations of Levothyroxine in the Treatment of Adult Hypothyroidism.
Brancato D; Scorsone A; Saura G; Ferrara L; Di Noto A; Aiello V; Fleres M; Provenzano V
Endocr Pract; 2014 Jul; 20(7):657-62. PubMed ID: 24449674
[TBL] [Abstract][Full Text] [Related]
8. Comparative Bioavailability of a Novel Solution and a Tablet Formulation of Levothyroxine.
Vandse S; Psarrakis Y; Washington K; Baron MA
Clin Pharmacol Drug Dev; 2023 May; 12(5):502-508. PubMed ID: 36876643
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Levothyroxine Sodium Soft Gelatin Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors: An Open-Label Study.
Sachmechi I; Lucas KJ; Stonesifer LD; Ansley JF; Sack P; Celi FS; Scarsi C; Lanzi G; Wartofsky L; Burman KD
Thyroid; 2023 Dec; 33(12):1414-1422. PubMed ID: 37885233
[No Abstract] [Full Text] [Related]
10. Analysis of dose-TSH response effect of levothyroxine soft-gel formulation.
Trimboli P; Piticchio T; Dadda Z; Stramazzo I; Gamarra E; Ruinelli L; Virili C
Front Endocrinol (Lausanne); 2024; 15():1340204. PubMed ID: 38449850
[TBL] [Abstract][Full Text] [Related]
11. Switch from tablet levothyroxine to oral solution resolved reduced absorption by intestinal parasitosis.
Tortora A; La Sala D; Vitale M
Endocrinol Diabetes Metab Case Rep; 2019 Mar; 2019():. PubMed ID: 30897550
[TBL] [Abstract][Full Text] [Related]
12. Liquid and softgel capsules of l-thyroxine results lower serum thyrotropin levels more than tablet formulations in hypothyroid patients.
Benvenga S
J Clin Transl Endocrinol; 2019 Dec; 18():100204. PubMed ID: 31844631
[TBL] [Abstract][Full Text] [Related]
13. Expert opinion on liquid L-thyroxine usage in hypothyroid patients and new liquid thyroxine formulation - Tirosint SOL [Opinia ekspertów dotycząca stosowania płynnej postaci lewotyroksyny oraz nowego preparatu Tirosint SOL u chorych na niedoczynność tarczycy].
Gietka-Czernel M; Hubalewska-Dydejczyk A; Kos-Kudła B; Lewiński A; Ruchała M; Syrenicz A; Zgliczyński W
Endokrynol Pol; 2020; 71(5):441-465. PubMed ID: 33202031
[TBL] [Abstract][Full Text] [Related]
14. Getting the levothyroxine (LT4) dose right for adults with hypothyroidism: opportunities and challenges in the use of modern LT4 preparations.
Gottwald-Hostalek U; Razvi S
Curr Med Res Opin; 2022 Nov; 38(11):1865-1870. PubMed ID: 35484983
[TBL] [Abstract][Full Text] [Related]
15. In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia.
Morini E; Catalano A; Lasco A; Morabito N; Benvenga S
Endocrine; 2019 Sep; 65(3):569-579. PubMed ID: 30919287
[TBL] [Abstract][Full Text] [Related]
16. Levothyroxine Therapy: Changes of TSH Levels by Switching Patients from Tablet to Liquid Formulation. A Systematic Review and Meta-Analysis.
Virili C; Giovanella L; Fallahi P; Antonelli A; Santaguida MG; Centanni M; Trimboli P
Front Endocrinol (Lausanne); 2018; 9():10. PubMed ID: 29434573
[TBL] [Abstract][Full Text] [Related]
17. The performance of levothyroxine tablet is impaired by bariatric surgery.
Trimboli P; Ossola N; Torre A; Mongelli F; Quarenghi M; Camponovo C; Lucchini B; Rotondi M; Ruinelli L; Garofalo F
Endocrine; 2023 Jun; 80(3):563-569. PubMed ID: 36581744
[TBL] [Abstract][Full Text] [Related]
18. Levothyroxine Therapy in Gastric Malabsorptive Disorders.
Virili C; Brusca N; Capriello S; Centanni M
Front Endocrinol (Lausanne); 2020; 11():621616. PubMed ID: 33584549
[TBL] [Abstract][Full Text] [Related]
19. Liquid levothyroxine improves thyroid control in patients with different hypothyroidism aetiology and variable adherence - case series and review.
Ruchała M; Bossowski A; Brzozka MM; Gietka-Czernel M; Hubalewska-Dydejczyk A; Kos-Kudła B; Lewiński A; Syrenicz A; Zgliczyński W
Endokrynol Pol; 2022; 73(5):893-902. PubMed ID: 36621916
[TBL] [Abstract][Full Text] [Related]
20. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
Ito M; Kawasaki M; Danno H; Kohsaka K; Nakamura T; Hisakado M; Yoshioka W; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
Thyroid; 2019 Oct; 29(10):1364-1370. PubMed ID: 31411123
[No Abstract] [Full Text] [Related]
[Next] [New Search]
